Study guide
2.3 Recordkeeping & Professional Guidelines
PTCB Hazardous Drug Management Certificate Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
0.1 Exam Facts, Format & Eligibility 0.2 Content Outline, Scoring & Registration 0.3 USP <800> Big Picture & How to Use This Guide
2 USP <800> Program Administration
1.1 USP <800> Scope, Purpose & Enforcement 1.2 The NIOSH Hazardous Drug List (2024 Update) 1.3 Assessment of Risk 1.4 Designated Person, SOPs & the Hierarchy of Controls
3 Training, Compliance & Recordkeeping
2.1 Training Requirements & Medical Surveillance 2.2 Hazard Communication, SDS & OSHA Requirements 2.3 Recordkeeping & Professional Guidelines
4 Primary Engineering Controls
3.1 Containment Primary Engineering Controls (C-PEC): BSCs & CACIs 3.2 Closed System Transfer Devices (CSTDs) 3.3 Nonsterile Controls and the C-SCA Distinction
5 Secondary Engineering Controls & Facility Design
4.1 Containment Secondary Engineering Controls (C-SEC): Negative Pressure & Air Exchange 4.2 Facility Layout: Storage, Unpacking & Sink Placement 4.3 Certification, ISO Classes & Emergency Equipment
6 Facility Cleaning Procedures
5.1 The Four-Step Cleaning Process 5.2 Wipe Sampling & Action Levels 5.3 Hazardous Waste Disposal & RCRA
7 Spill Response & Cleaning PPE
6.1 Spill Kits & Spill Response Procedures 6.2 PPE During Cleaning: Glove Change Frequency & Disposal
8 Dispensing & the Compounding Interface
7.1 USP <795>/<797> Interface for Hazardous Drugs 7.2 High-Risk Oral Hazardous Drugs 7.3 Tablet Splitting & Crushing Restrictions
9 Counting, Packaging & Patient Counseling
8.1 Counting, Packaging & Dedicated Equipment 8.2 Patient Counseling & Unit-Dose Labeling
10 PPE: Gloves, Gowns & Task-Based Selection
9.1 ASTM D6978 Chemotherapy Gloves & Double Gloving 9.2 Chemo Gowns & Gown Change Frequency 9.3 Task-Based PPE Selection
11 Respiratory Protection, Eye Protection & PPE Sequencing
10.1 Respiratory & Eye/Face Protection 10.2 Donning & Doffing Sequence
12 Transport & Receiving
11.1 Receiving Hazardous Drug Shipments 11.2 Internal Transport & Storage 11.3 Damaged/Leaking Shipments & Chain of Custody
13 Exam Readiness & Final Review
12.1 Domain-by-Domain Quick Review 12.2 Common Exam Traps & Final Checklist
2.3 Recordkeeping & Professional Guidelines
Key Takeaways Explain This Topic AI
Maintain current HD SOPs and documented competency assessments; review SOPs at least every 12 months and document the review.
USP <800> recommends wipe sampling and medical surveillance; document activities actually performed and check any additional applicable obligations.
Under 29 CFR 1910.1020, covered exposure records generally require 30 years and covered medical records employment plus 30 years, subject to the rule’s exceptions.
Employee medical confidentiality is distinct from the retrievability of operational records; access depends on the applicable authority and conditions.
The entity HD list includes relevant NIOSH-listed drugs the entity handles and must be reviewed at least every 12 months.
Last updated: October 2026
Identify the record, its purpose and the applicable rule
A hazardous-drug (HD) program needs records that show what was actually done: which procedures were in force, who was trained, what incidents occurred and how problems were addressed. The important distinction is between a required activity , a recommended program and a record created when an activity occurs . These are not interchangeable categories.
USP's January 2026 FAQ expressly identifies environmental wipe sampling and medical surveillance as recommended, rather than universally required, under USP <800>. Other applicable regulations, oversight requirements or facility policies may impose additional duties. Assess those duties on their own terms instead of attributing every local program requirement to USP.
Maintain current procedures and competency evidence
Written standard operating procedures (SOPs) should address the HD activities carried out at the facility. The designated person must review the SOPs at least every 12 months and document that review. Changes to procedures and records must be communicated to the personnel affected.
Training and competency assessment also require documentation. Records should make it possible to connect a worker's assessed competencies with the tasks the worker performs. A dated attendance list can show that a class occurred; it does not, by itself, establish that every person demonstrated the relevant technique successfully.
Record category Useful contents Important boundary
SOPs and review history Approved procedure, version, review date and responsible person An obsolete procedure is not evidence of a current process
Training and competency Worker, date, task, assessment and follow-up A course certificate does not automatically prove local practical competency
Spill or exposure incident Facts of the event, response, affected tasks and corrective action Document actual events; do not invent incidents to populate a log
Wipe sampling, when performed Sampling plan, locations, results, methods and follow-up Recommended by USP; not a universal USP sampling mandate
Medical surveillance, when operated Occupational-health records and follow-up Confidential medical information requires appropriate access controls
Keep a usable process for documenting spills and exposures even if there has been no incident. An empty incident record may accurately reflect events; it does not by itself prove either a safe workplace or a failure to comply. If an incident occurred, failure to document and investigate it is a different issue from having no incident to record.
Use sampling results to improve controls
Wipe sampling can help assess surface contamination and the effectiveness of containment and work practices. USP's FAQ says there is no established universal acceptable limit for HD surface contamination. A result should therefore be interpreted with the sampling method, locations, drugs measured and local program in view.
If contamination is found, identify, document and address its cause. The response may involve work-practice review, retraining, deactivation and decontamination, cleaning or engineering-control improvements. Follow-up sampling can help evaluate whether corrective measures worked. Do not substitute a bare statement that a number was “below the safe limit” when no applicable limit or method has been identified.
Where sampling is performed, preserve the information needed to interpret it. A result without its sampling location, method or units may be difficult to compare with a later result. Records of an optional program can still fall under legally applicable retention and access requirements.
Keep the facility HD list specific and current
The entity must maintain its own list of HDs, including items on the current NIOSH list that the entity handles . This does not mean copying every NIOSH-listed drug into a local inventory regardless of whether it is present. Review the local list at least every 12 months and assess new agents or dosage forms as they are introduced.
The January 2026 USP FAQ identifies the 2024 NIOSH list as the current list. Manufacturer information and the NIOSH criteria also matter when evaluating drugs not yet captured in that published list. A new drug's absence from the list is not, by itself, proof that the drug is nonhazardous.
Retention: do not overlook OSHA's federal requirements
There is no single retention period that can be applied indiscriminately to every HD-related document. However, that does not mean retention is governed only by state pharmacy rules or accreditation policy.
29 CFR 1910.1020 applies to covered employee exposure and medical records, including records not independently required to be created by a specific OSHA standard. Subject to its scope, exceptions and any different period in a specific applicable standard:
Employee exposure records: preserve for at least 30 years .
Employee medical records: preserve for the duration of employment plus 30 years .
Certain background monitoring data may be retained for one year if the specified results, methodology and interpretive information are retained for 30 years.
Certain separately maintained insurance and minor first-aid records are excepted. Medical records for employment lasting less than one year need not be retained beyond employment if provided to the worker on termination, under the rule's stated conditions.
Classify the record before applying a schedule. A wipe-sampling record can be an employee exposure record; a confidential medical examination can be an employee medical record. Neither should be assigned an arbitrary short pharmacy-document retention period without checking the applicable requirements.
Access and the roles of professional organisations
OSHA's rule provides access rights for employees, qualifying representatives and authorised OSHA personnel, with specific conditions. It also preserves obligations concerning medical confidentiality. Do not assume that every inspector, accreditor or line manager is entitled to an unrestricted copy of every worker's clinical file.
NIOSH supplies occupational-health research and recommendations, including the HD list. OSHA administers workplace-safety requirements. USP develops compendial standards; their application and enforcement must be understood in the relevant jurisdiction. The American Society of Health-System Pharmacists (ASHP) and Oncology Nursing Society (ONS) provide professional guidance; their documents do not independently turn every recommendation into a government regulation.
Consider an inspection request for a technician's competency record. The relevant response is to retrieve the actual training and assessment evidence for the assigned tasks, identify any missing or expired assessment, and address it. The absence of a wipe-sampling result is not automatically a violation of a universal USP sampling requirement. Separately check whether that facility's applicable rules or adopted program required sampling and whether records already created were retained properly.